Geoffrey L. Ray

Radiation Oncology
655 Watkins Mill Rd
Gaithersburg, MD 20879

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Pre-Clinical Assessment of Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease.

Pre-Clinical Assessment of Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 10, 2012
Showing 1-1 of 1

Last Updated: 09/26/2026